What is Touch Bionics?
Touch Bionics, now operating under the umbrella of Össur Touch Solutions, is a pioneer in the field of advanced prosthetic technologies. The company focuses on restoring functionality and quality of life for individuals with upper limb deficiencies through a sophisticated product portfolio that includes myoelectric prosthetic hands, partial hand solutions, and highly realistic passive silicone prostheses. Beyond hardware, the firm distinguishes itself by providing comprehensive clinical support and training services, ensuring that both practitioners and end-users are equipped to maximize the utility of their prosthetic devices. This holistic approach to patient care and technological precision has solidified its reputation as a critical player in the global assistive technology market.
How much funding has Touch Bionics raised?
Touch Bionics has raised a total of $11.5M across 4 funding rounds:
Multiple Rounds
$7.7M
Unspecified
$3.9M
Unspecified (2010): $1.3M with participation from Archangels
Debt (2010): $2.5M led by Clydesdale Bank
Other Financing Round (2010): $3.9M supported by Clydesdale Bank
Unspecified (2011): $3.9M featuring Scottish Venture Fund and Archangel Investors Limited
Key Investors in Touch Bionics
Scottish Venture Fund
A national economic development agency and non-departmental public body of the Scottish Government focused on fostering innovation and regional growth.
Archangels
A prominent investment group specializing in early-stage technology and life sciences ventures with a focus on high-growth potential companies.
Clydesdale Bank
A established financial institution providing comprehensive banking and commercial lending services to support corporate development and operational scaling.
What's next for Touch Bionics?
With the support of its recent strategic financing, Touch Bionics is well-positioned to accelerate its research and development initiatives, potentially expanding its reach into new international markets and refining its existing product lines. The focus remains on enhancing the user experience through improved sensory feedback and more intuitive control interfaces for myoelectric devices. As the company continues to integrate with broader healthcare ecosystems, the emphasis will likely shift toward scaling its clinical support infrastructure to meet the growing demand for personalized prosthetic care. This strategic expansion is expected to drive long-term value, reinforcing the company's role as a cornerstone of modern rehabilitative medicine.
See full Touch Bionics company page
